Concerns Regarding Overuse of Carbapenems and Emerging Antimicrobial Resistance in Tertiary Care Hospitals

Authors

  • Pareshkumar M Patel Surat Municipal Institute of Medical Education and Research, Surat, India

Keywords:

Carbapenem overuse, antimicrobial resistance, carbapenem-resistant Enterobacteriaceae, antimicrobial stewardship, tertiary care hospitals

References

1. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance 2014. Geneva: WHO; 2014. Available from: https://www.who.int/publications/i/item/9789241564748

2. Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. Atlanta: CDC; 2013. Available from: https://www.cdc.gov/drugresistance/threat-report-2013

3. Kollef MH. Broad-spectrum antimicrobials and the treatment of serious bacterial infections: getting it right up front. Clin Infect Dis. 2000;31(S2):S131-8. DOI: https://doi.org/10.1086/314079

4. Nordmann P, Naas T, Poirel L. Global spread of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Rev. 2011;24(3):689-707. DOI: https://doi.org/10.1128/CMR.00029-11

5. Livermore DM. Has the era of untreatable infections arrived? J Antimicrob Chemother. 2009;64(S1):i29-i36. DOI: https://doi.org/10.1093/jac/dkp255

6. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: clinical update. Clin Microbiol Rev. 2005;18(4):657-86. DOI: https://doi.org/10.1128/CMR.18.4.657-686.2005

Downloads

Published

2016-01-01

How to Cite

Patel, P. M. (2016). Concerns Regarding Overuse of Carbapenems and Emerging Antimicrobial Resistance in Tertiary Care Hospitals. International Journal of Medical Research, 4(01), 11–12. Retrieved from https://ijmrinternational.in/index.php/ijmr/article/view/95

Issue

Section

Letter to Editor